The whole blood TREM-1 expression has been described as a predictive marker for anti-TNF mAb therapy responsiveness in patients with IBD (3, 9, 10) Interestingly, while both Gaujoux et al. This evidence concerns the gene TREM1 and inflammatory bowel disease.